Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Dec 8, 2006

Rimonabant update in the United States
Dec 5, 2006

New data shows Rimonabant benefited patients with type 2 diabetes by improving blood sugar control, reducing weight and acting on other cardiometabolic risk factors

First Rimonabant Trial with HbA1c as a Primary Endpoint
Nov 27, 2006

Sanofi Pasteur Completes Shipment of 50 Million Doses of Influenza Vaccine

Sanofi pasteur able to produce additional vaccine to meet customer demand
Nov 20, 2006

Sanofi Pasteur Signs Contract with U.S. Government for Stockpile of New Type of H5N1 Pre-Pandemic Vaccine

New pre-pandemic vaccine will provide additional level of preparedness
Oct 31, 2006

First 9th months of 2006: Sales growth of 2.6% on a comparable basis - Adjusted EPS growth of 15.0%, or 7.5% excluding selected items

Sales Growth of 2.6% on a Comparable Basis(1)
Oct 30, 2006

New study shows SCULPTRA® (injectable poly-l-lactic acid), a unique class of injectable for cosmetic use, provides 13 month results

Comparative Clinical Trial Results Announced for the Treatment of Nasolabial Folds at the 2006 American Society of Dermatologic Surgery (ASDS) Annual Meeting
Oct 18, 2006

TAXOTERE® receives U.S. FDA approval for the treatment of patients with head and neck cancer

Taxotere(R)-based regimen demonstrates a significantly longer progression free survival and 29 percent reduction in the risk of mortality in patients with inoperable locally advanced head and neck cancer
Oct 18, 2006

FDA approves ALLEGRA® (fexofenadine hydrochloride) oral suspension for treatment of seasonal allergy symptoms and chronic idiopathic urticaria

New formulation provides non-impairing symptom relief for pediatric populations
Oct 12, 2006

Sanofi Pasteur Remains on Track to Deliver 50 Million Doses of Influenza Vaccine to U.S. Market for 2006-2007 Season

As communicated by CDC, majority of supply will be available in October and November; sanofi pasteur shipped one-third of influenza vaccine planned for 2006-2007 season
Sep 29, 2006

Sanofi Pasteur and the Pediatric Dengue Vaccine Initiative Partner Against Dengue Fever

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.